Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03306849 · ClinicalTrials.gov registry record
Ultrasonographic Evaluation of Anovulatory Disorders in Lean and Overweight Women
A clinical trial, sponsored by Cornell University.
- Completed
- Registry status
- 59
- Enrollment target
NCT03306849: Completed study, sponsored by Cornell University.
NCT03306849 is a clinical trial that has completed, run by Cornell University. The registered enrollment target is 59 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03306849 has completed, sponsored by Cornell University.
- COMPLETED
- Registry status
- 59 participants
- Enrollment target
Study Summary
The investigators would like to determine whether ultrasound features of the ovaries can be used to reliably diagnose different types of anovulatory disorders in women across all body types. The study will also try to establish whether ultrasound features of the ovary can reflect the degree of reproductive and metabolic problems that a woman with irregular or absent periods might be experiencing.
Primary Outcome
The number and size of all follicles in each ovary will be assessed by ultrasonography
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 59 participants |
| Start Date | 2015-08 |
| Est. Completion | 2023-04 |
What the finished NCT03306849 record still lists
NCT03306849 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 59 participants, a relatively small participant target.
The record links to 0 conditions, and to 0 interventions.
NCT03306849 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03306849 about?
NCT03306849 is a clinical study titled "Ultrasonographic Evaluation of Anovulatory Disorders in Lean and Overweight Women". The investigators would like to determine whether ultrasound features of the ovaries can be used to reliably diagnose different types of anovulatory disorders in women across all body types. The study will also try to establish whether ultrasound features of the ovary can reflect the degree of repro...
What is the current status of trial NCT03306849?
This trial is currently completed. The enrollment target is 59 participants. The study started on 2015-08. Estimated completion is 2023-04.
Who is sponsoring clinical trial NCT03306849?
This trial is sponsored by Cornell University, which has 66 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03801083 · 59 participants · Phase 2
Adoptive Transfer of Tumor Infiltrating Lymphocytes for Biliary Tract Cancers
- NCT04332367 · 59 participants · Phase 2
Carboplatin, Taxane And Ramucirumab for Patients With NSCLC After Pemetrexed or Pembrolizumab Maintenance
- NCT05489575 · 59 participants · NA
CPAP for the Treatment of Supine Hypertension
- NCT06721689 · 59 participants · Phase 1
PEEL-224, Vincristine and Temozolomide in Pediatric Solid Tumors
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia